10-Q: Concentra Health Reports Strong Q3 2026 Growth

Concentra Group Holdings Parent, Inc. announced a significant increase in revenue and net income for the third quarter of 2026, driven by organic growth and strategic acquisitions.

Summary

• Revenue for the third quarter of 2026 increased by 8.6% to $622.1 million compared to the same period in 2025.
• For the nine months ended September 30, 2026, revenue grew by 10.7% to $1,797.7 million.
• Net income attributable to the Company for the third quarter of 2026 was $65.9 million, or $0.52 per diluted share, up from $48.3 million, or $0.38 per diluted share, in Q3 2025.
• Total patient visits in occupational health centers increased by 4.9% in Q3 2026 compared to Q3 2025.
• The company maintained a strong liquidity position with $85.8 million in cash and $430.3 million in availability under its revolving credit facility as of September 30, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with strong revenue growth and improved profitability, though some operational expenses have increased.

Positives

• Revenue growth of 8.6% in Q3 2026 and 10.7% year-to-date demonstrates strong top-line performance.
• Net income attributable to the Company increased significantly to $65.9 million in Q3 2026 from $48.3 million in Q3 2025.
• Patient visit volume in occupational health centers saw a healthy increase of 4.9% in Q3 2026.
• Revenue per visit also increased by 3.3% in Q3 2026, indicating improved pricing power or service mix.
• The company has a strong liquidity position with substantial cash reserves and available credit.
• Leverage ratio improved to 2.90x as of September 30, 2026, well within the covenant limit.

Negatives

• General and administrative expenses increased as a percentage of revenue, primarily due to planned additions of full-time employees and costs associated with operating as a standalone public company.
• The company is involved in several significant legal proceedings, including a data breach litigation and investigations related to billing practices, which could result in substantial liabilities.
• Transition services agreement fees paid to Select are ongoing, though scheduled to cease in November 2026.

Risks

• Potential for significant uninsured liabilities from ongoing litigation and regulatory proceedings.
• The company's operations are subject to extensive federal and state laws and regulations, including those related to data privacy and security.
• Labor shortages and increased employee turnover or costs could significantly increase operating expenses.
• Adverse changes in relationships with employer customers, third-party payors, or workers compensation provider networks.
• The company's reliance on third-party vendors introduces additional risks.
• Potential for negative publicity that could lead to increased governmental and regulatory scrutiny.

Future Outlook

The company expects to continue growing through strategic acquisitions and de novo center development. Management believes its internally generated cash flows and revolving credit facility provide sufficient liquidity for short and long-term operations.

Management Comments

• The company's national presence enables it to provide access to high-quality care that supports its mission to improve the health of America's workforce.
• Management believes that the number of patient visits is the single most important indicator of the volume of services being provided in our centers.
• We believe our internally generated cash flows and borrowing capacity under our Revolving Credit Facility will allow us to finance our operations in both the short and long term.

Industry Context

StockSavvy.ai notes that Concentra's performance aligns with broader trends in the occupational health sector, characterized by increasing demand for employer services and workers' compensation care, driven by a focus on workforce health and safety.

Comparison to Industry Standards

• Concentra's revenue per visit for workers compensation services ($219.24 in Q3 2026) appears strong compared to general industry benchmarks, reflecting effective pricing and reimbursement strategies.
• The company's Adjusted EBITDA margin of 22.5% in Q3 2026 indicates robust operational efficiency, potentially outperforming some competitors in the fragmented occupational health market.
• The company's scale as the largest provider of occupational health services by location count provides a competitive advantage not easily replicated by smaller regional players.

Legal Proceedings

• The company is involved in various legal actions, including claims for professional malpractice, general liability, wage and hour class action lawsuits, and data breaches.
• A qui tam lawsuit under the California Insurance Frauds Prevention Act alleges submission of false claims and retaliation against a whistleblower.
• The company received a subpoena from the California Department of Insurance related to an investigation of billing and coding for physical therapy claims.
• Six putative class action lawsuits have been filed against PJ&A and Concentra related to a data breach at a third-party vendor, Perry Johnson & Associates, Inc.
• The DOJ is investigating Select (former parent) and Concentra for potential violations of the False Claims Act related to physical therapy services billing.

Related Party Transactions

• On August 21, 2026, the Company repurchased 1.0 million shares of common stock from Robert A. Ortenzio, chairman of the Board of Directors, for $34.65 million.
• Transition services agreement fees are paid to Select Medical Corporation for shared support functions, totaling $0.4 million for Q3 2026 and $3.0 million year-to-date.

Stakeholder Impact

• Shareholders benefit from increased revenue, net income, and earnings per share, as well as a new $250 million share repurchase program.
• Employees may see increased personnel costs due to planned additions of full-time employees.
• Patients are subject to potential impacts from ongoing legal proceedings, particularly those related to data breaches and billing practices.
• Creditors are protected by the company's strong liquidity position and improved leverage ratio.

Next Steps

• Continue to grow through strategic acquisitions and de novo center development.
• Manage operational expenses, particularly general and administrative costs, to maintain profitability.
• Monitor and address ongoing legal proceedings and regulatory investigations.
• The transition services agreement with Select is scheduled to cease in November 2026.

Key Dates

Recommendation

The company demonstrates strong operational performance with significant revenue and profit growth. However, ongoing legal proceedings and increased G&A expenses warrant a cautious approach. The new share repurchase program is positive, but the resolution of legal matters remains a key factor for future upside.

Keywords

Occupational Health, Workers Compensation, Employer Services, Onsite Health Clinics, Revenue Growth, Financial Performance, Healthcare Services, Patient Visits